Suppr超能文献

在终末期肝病治疗中引入姑息治疗:一项集群随机对照试验的研究方案。

Introducing Palliative Care within the Treatment of End-Stage Liver Disease: The Study Protocol of a Cluster Randomized Controlled Trial.

机构信息

Department of Digestive Diseases and Transplantation, Einstein Healthcare Network, Philadelphia, Pennsylvania.

Department of Biostatistics, Duke Clinical Research Institute, Durham, North Carolina.

出版信息

J Palliat Med. 2019 Sep;22(S1):34-43. doi: 10.1089/jpm.2019.0121.

Abstract

Patients with end-stage liver disease (ESLD) suffer from myriad symptoms due to the systemic effects of the disease and unpredictable acute episodes, which contribute to progressive deterioration in quality of life (QOL). Despite clear evidence that palliative care (PC) improves QOL in other serious illnesses, PC is underutilized and delayed for ESLD patients. Through a comparative effectiveness trial of specialist led consultative PC (Model 1) versus trained hepatologist led PC (Model 2), we aim to build evidence on introducing PC into the routine outpatient care of ESLD patients. We hypothesize that trained hepatologist led PC model will have a better improvement in QOL compared to consultative PC model. This two-arm, multicenter cluster-randomized trial assesses the effectiveness of two PC models for patients with ESLD. Fourteen clinical centers will recruit 1260 patient-caregiver dyads. Each center is the unit of randomization. Hepatologists at sites randomized to the Model 2 have undergone web-based training in the principles of PC as pertained to ESLD. PC intervention is delivered over four visits (initial, one, two, and three months). Follow-up assessments occur at 6, 9, and 12 months. Eligible patients are those with new onset or ongoing complications of ESLD with a caregiver willing to participate. The primary outcome is change in patients' QOL from baseline to three months. Secondary outcomes include symptom burden, depression, distress, satisfaction with care, caregiver burden and QOL, goal concordant care, and health care utilization. A research advisory board has been developed with representatives from the participating centers, who have provided active feedback on the protocol, outcomes, study methods, and training program. Intervention fidelity will be maintained by adherence to a visit agenda and providers in both models completing a PC checklist after each study visit.

摘要

终末期肝病 (ESLD) 患者由于疾病的全身影响和不可预测的急性发作而遭受多种症状,导致生活质量 (QOL) 逐渐恶化。尽管有明确的证据表明姑息治疗 (PC) 可改善其他严重疾病的 QOL,但在 ESLD 患者中,PC 的利用率较低且延迟。通过对专家主导的咨询性 PC(模型 1)与经过培训的肝病专家主导的 PC(模型 2)的比较有效性试验,我们旨在为将 PC 引入 ESLD 患者的常规门诊护理提供证据。我们假设经过培训的肝病专家主导的 PC 模式在改善 QOL 方面将优于咨询性 PC 模式。这项两臂、多中心聚类随机试验评估了两种 PC 模式对 ESLD 患者的有效性。14 个临床中心将招募 1260 对患者-照顾者。每个中心都是随机分组的单位。随机分配到模型 2 的站点的肝病专家已经接受了关于 ESLD 的 PC 原则的基于网络的培训。PC 干预在四次就诊中进行(初始、一次、两次和三个月)。随访评估在 6、9 和 12 个月进行。符合条件的患者是那些患有新发作或正在发生的 ESLD 并发症且有照顾者愿意参与的患者。主要结局是患者从基线到三个月时的 QOL 变化。次要结局包括症状负担、抑郁、痛苦、对护理的满意度、照顾者负担和 QOL、目标一致的护理以及医疗保健利用情况。已经成立了一个研究咨询委员会,由参与中心的代表组成,他们对方案、结局、研究方法和培训计划提供了积极的反馈。通过遵守就诊议程和两种模式中的提供者在每次研究就诊后完成 PC 检查表,可以保持干预的一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验